Live Case from MedStar Washington Hospital Center | Washington, DC

Monday, March 10, 2025

4:07 PM - 4:52 PM ET

Live Case Operator(s)

Nelson L. Bernardo, MD, FSCAI

Medical Director
MedStar Heart and Vascular Institute at MedStar Washington Hospital Center
Washington, District of Columbia, United States

No relationships to disclose

Moderator(s)

Timir Paul, MD, PhD, FACC, FSCAI

Professor of Medicine; Program Director, Cardiovascular Disease Fellowship
University of Tennessee Health Science Center- Nashville, Ascension St. Thomas Hospital
Brentwood, Tennessee, United States

No relationships to disclose
Sameh Sayfo, MD, MBA, FSCAI, FACC

Endovascular fellowship program director
Baylor Scott & White The Heart Hospital Plano
Plano, Texas, United States

Disclosure information not submitted.
Eric A. Secemsky, MD, MSc

Director of Vascular Intervention
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

No relationships to disclose

Panel Discussant(s)

Gary M. Ansel, MD, FACC

Founder
Healthcare Inroads
Columbus , Ohio, United States

No relationships to disclose
Subhash Banerjee, MD

Chief of Cardiovascular Research & Innovation
Baylor Scott & White Heart and Vascular Institute, Dallas, TX
Dallas, Texas, United States

Disclosure information not submitted.
Riyaz Bashir, MD

Director Vascular and Endovascular Medicine
Temple University Hospital
Mount Laurel, New Jersey, United States

No relationships to disclose
Robert E. Beasley, MD, FSIR, FSCAI

Director of Research and Endovascular Specialist
Palm Vascular Centers of MB and Coral Gables
Miami, Florida, United States

No relationships to disclose
S. Jay Mathews, MD

Director, Cardiac Cath Lab, PERT, & Structural Heart
Manatee Memorial Hospital

No relationships to disclose
Aravinda Nanjundappa, MD, FSCAI

Director of Peripheral Vascular Interventions, Cardiovascular Division
Cleveland Clinic , Main Campus
Pepper pike, Ohio, United States

No relationships to disclose
Khusrow A. Niazi, MD, FACC, FSCAI, FSVM

Director Peripheral Vascular Interventions
Emory University
Dunwoody, Georgia, United States

Disclosure information not submitted.
Gregory Piazza, MD

Staff Physician
Brigham and Women's Hospital
Boston, Massachusetts, United States

No relationships to disclose

Disclosure(s):

Nelson L. Bernardo, MD, FSCAI: No financial relationships to disclose

Timir Paul, MD, PhD, FACC, FSCAI: No financial relationships to disclose

Sameh Sayfo, MD, MBA, FSCAI, FACC: AngioDynamics: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific, Inari, Medtronic, Philips, Shockwave: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cagent Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Inari Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Jupiter Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Penumbra, Inc.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Eric A. Secemsky, MD, MSc: Abbott, BD, Boston Scientific, Cook, Cordis, Endovascular Engineering, Gore, InfraRedx, Medtronic, Philips, RapidAI, Rampart, Shockwave, Siemens, Teleflex, Terumo, Thrombolex, VentureMed, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Gary M. Ansel, MD, FACC: akura medical: Consultant (Ongoing); BSC: Consulting Fees (e.g., advisory boards) (Ongoing); Cook Medical: Consultant (Ongoing), royalties (Ongoing); Efemoral Medical, Inc.: Stock-privately held company (Ongoing); Healthcare inroads: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing); mercator: Consultant (Terminated, April 1, 2024); Otsuka Pharmaceuticals: Consultant (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing); sentante: Consultant (Ongoing); surmodics: royalties (Ongoing)

Subhash Banerjee, MD: AngioSafe: Consulting Fees (e.g., advisory boards) (Ongoing); Espirion: Grant/Research Support (Ongoing); GE Healthcare Bio-Sciences: Grant/Research Support (Ongoing); Kaneka: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Novartis: Grant/Research Support (Ongoing)

Riyaz Bashir, MD: Thrombolex: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Robert E. Beasley, MD, FSIR, FSCAI: No financial relationships to disclose

S. Jay Mathews, MD: Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Akura: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Bolt Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cardiva: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CONTEGO MEDICAL: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Cordis, Endovascular Division: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Evident Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Innova Vascular Inc: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Intellvasc: Consultant (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Protexa: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); W. L. Gore: Grant/Research Support (Ongoing)

Aravinda Nanjundappa, MD, FSCAI: No financial relationships to disclose

Khusrow A. Niazi, MD, FACC, FSCAI, FSVM: No financial relationships to disclose

Gregory Piazza, MD: BMS/Pfizer, Janssen, Bayer, Amgen, BSC, Esperion, NIH 1R01HL164717-01, Alexion: Grant/Research Support (Ongoing); BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Consulting Fees (e.g., advisory boards) (Ongoing)